Dr. Daniel Kuritzkes has served as our Division Chief since January 2012. Dr. Kuritzkes had previously served as the Associate Division Chief under Dr. Elliott Kieff. Dr. Kuritzkes is a Professor of Medicine and current Chair of the national AIDS Clinical Trials Group Network, an N.I.H. funded international network that conducts clinical trials of novel therapeutics in HIV/AIDS, tuberculosis, and viral hepatitis. Dr. Kuritzkes also directs the Partners/Harvard AIDS Clinical Trials Unit and the Harvard Center for AIDS Research Program in HIV Therapeutics.
Dr. Paul Sax is the Division’s Medical Director. Dr. Sax directs the BWH HIV program, and is an internationally recognized expert in HIV clinical care. Besides his clinical leadership roles, Dr. Sax is the course director for the HMS rotation in infectious diseases and for two HMS postgraduate courses.
Dr. James Maguire returned to the BWH in 2008 after a brief interval with the CDC, as a Master Clinician and Teacher in Infectious Diseases. He is an international expert in parasitology and tropical medicine.
Dr. Lindsey Baden is Director of the BWH/DFCI Infectious Diseases Immune-Compromised Host inpatient and outpatient consultative services and also serves as the Division's Director of Clinical Research.
Drs. Richard Platt and Deborah Yokoe co-direct the BWH and DFCI hospital epidemiology programs, study the prevention of morbidity from infection and antimicrobial use in the BWH, DFCI, and HVMA network, and oversee Dr. Thomas O’Brien’s group in WHONET international surveillance of antibiotic resistance. Dr. Yokoe serves as the hospital epidemiologist for BWH and DFCI and Dr. Michael Klompas serves as Associate Hospital Epidemiologist.
Please visit the "Our Research" page in order to learn more about the division's research projects.
Dr. Lindsey Baden talks with the Boston Herald about Lyme disease prevention
Dr. Paul Sax <http://www.medscape.com/viewarticle/835920> joins Medscape in a video interview to review the top stories in HIV medicine for 2014.
Dr. Paul Sax talks about a hepatitis C drug and serious interactions <http://www.forbes.com/sites/larryhusten/2015/03/23/gilead-hepatitis-drugs-tripped-by-old-heart-drug/>
Dr. Lindsey Baden <http://nhpr.org/post/ebola-response-nh-facts-fears-and-policy> speaks with New Hampshire Public Radio about Ebola.
Dr. Daniel Kuritzkes <http://www.myfoxboston.com/clip/10821056/what-is-norovirus-and-how-does-it-spread> joins Fox 25 to discuss Norovirus and how it is spread.
Dr. Matthew Waldor <http://www.nytimes.com/2014/10/31/health/genes-influence-ebola-infections-in-mice-study-suggests.html?_r=2> comments in a New York Times piece about a recent study that found that genes influence how mice react to Ebola.
NBC News interviews Dr. Lindsey Baden <http://www.nbcnews.com/storyline/ebola-virus-outbreak/president-obama-speaks-out-ebola-quarantine-orders-n236026> about the risk of Ebola contagion in early symptomatic stages.
Dr. Daniel Kuritzkes joins Fox 25 to discuss the recent case of Ebola in New York.
Dr. Deborah Yokoe talks with The Boston Globe about the inconsistency in hospitals’ policies in Massachusetts for staff returning from relief work in West Africa.
Dr. Kuritzkes speaks with The Boston Herald about the barriers to determining the effectiveness of experimental Ebola therapies.
In a Boston Herald article, Dr. Kuritzkes weighs in about the recent implementation of mandatory quarantines in New York and New Jersey for medical workers and other travelers who have had contact with Ebola patients.
Initiate pilot clinical trials of investigational approaches to eliminating the HIV reservoir in latently infected cells.
Apply functional MRI and SPECT scanning to study effects of antiretroviral drugs with known CNS side effects.
Develop educational programs for broad-based education and care in resource limited settings.
Develop a laboratory-based research program in fungal pathogenesis.
Better define the fundamental cell biology of mycobacteria and targets for new antibiotics.
Understand community, population, and social dynamics within the human intestinal microbiota.
Understand how enteric pathogens interact with gut microbes at the site of the infection.
Improve the pipeline for development of low-cost point-of-care diagnostics for TB, HIV, and other infections.
Determine the mechanism by which bacterial glycosaminoglycan-binding determines infection outcome.
Develop approaches to prevent/treat infections by interfering with glycosaminoglycan-binding.
Raise endowment funds to improve research opportunities.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.